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Background: Successful delivery of compounds to the brain and retina is a challenge in the development of
therapeutic drugs and imaging agents. This challenge arises because internalization of compounds into the brain
and retina is restricted by the blood–brain barrier (BBB) and blood-retinal barrier (BRB), respectively. Simple and
reliable in vivo assays are necessary to identify compounds that can easily cross the BBB and BRB.
Methods: We developed six fluorescent indoline derivatives (IDs) and examined their ability to cross the BBB and
BRB in zebrafish by in vivo fluorescence imaging. These fluorescent IDs were administered to live zebrafish by
immersing the zebrafish larvae at 7-8 days post fertilization in medium containing the ID, or by intracardiac
injection. We also examined the effect of multidrug resistance proteins (MRPs) on the permeability of the BBB and
BRB to the ID using MK571, a selective inhibitor of MRPs.
Results: The permeability of these barriers to fluorescent IDs administered by simple immersion was comparable to
when administered by intracardiac injection. Thus, this finding supports the validity of drug administration by
simple immersion for the assessment of BBB and BRB permeability to fluorescent IDs. Using this zebrafish model,
we demonstrated that the length of the methylene chain in these fluorescent IDs significantly affected their ability
to cross the BBB and BRB via MRPs.
Conclusions: We demonstrated that in vivo assessment of the permeability of the BBB and BRB to fluorescent IDs
could be simply and reliably performed using zebrafish. The structure of fluorescent IDs can be flexibly modified
and, thus, the permeability of the BBB and BRB to a large number of IDs can be assessed using this zebrafish-based
assay. The large amount of data acquired might be useful for in silico analysis to elucidate the precise mechanisms
underlying the interactions between chemical structure and the efflux transporters at the BBB and BRB. In turn,
understanding these mechanisms may lead to the efficient design of compounds targeting the brain and retina.
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Delivery of compounds to the brain and retina has been
an immense challenge in the development of therapeutic
drugs and imaging agents [1-8]. Although there are several
active internalization mechanisms that can shuttle neces-
sary nutrients into the brain and retina, internalization of
molecules is restricted by the blood-brain barrier (BBB)
and blood-retinal barrier (BRB), respectively, which main-
tain homeostasis of these organs [2]. An important con-
stituent of the BBB and BRB is the physical barrier formed
by tight junctions between endothelial cells to seal the vas-
cular lumen. The penetration of hydrophilic solutes via
the intercellular cleft is severely restricted by the tight
junction barrier and only lipophilic compounds with low
molecular weight can passively diffuse into the brain and
retina by a transcellular route [2]. However, most lipo-
philic molecules that diffuse into the brain and retina
are eliminated by active efflux transporters such as
P-glycoprotein (Pgp), multidrug resistance proteins
(MRPs), and breast cancer resistance protein (BCRP) [1,9].
Since these efflux transporters have broad substrate spec-
trums, most endogenous and exogenous lipophilic mole-
cules are unable to reach the brain. Indeed, over 98% of
small molecules intended for therapeutic use in the cen-
tral nervous system never reach the market because of
their inherent inability to cross the BBB [3].
Simple and reliable in vivo assays are important to
identify compounds that can permeate the BBB and
BRB. A number of techniques are available for in vivo
measurement of brain uptake, including methods based
on equilibrium studies between the blood and brain, and
methods based on kinetic parameters [10]. The equilib-
rium distribution of a compound between the blood and
brain is defined as the ratio of the concentration in the
brain and blood (logBB) [10]. This parameter depends
upon passive diffusion characteristics, transporters at the
BBB, metabolism, and differences between the relative
drug binding affinity of plasma proteins and brain tis-
sues. Although logBB measurements provide important
information about brain permeability, they usually re-
quire several animals per time-point and are therefore
costly and labor intensive [10]. Positron emission tomog-
raphy has been shown to be a noninvasive, quantitative
approach for evaluating kinetic parameters of the uptake
of compounds by the brain through the capture of
multi-dimensional images in real time [10]. However,
the preparation and stability of tracers are matters of
concern [10]. Therefore, if in vivo assays for the assess-
ment of the permeability of the BBB and BRB to a com-
pound can be performed in a high-throughput manner,
identification of compounds that can easily cross these
barriers will be accelerated. Furthermore, the large
amount of data obtained from a high-throughput assay
can be used for in silico analysis, which has beenextensively developed and can greatly contribute to
designing and predicting compounds able to cross the
BBB and BRB.
Recent developments in combinatorial chemistry have
enabled the construction of a diversity-oriented fluores-
cence chemical library [11]. It has been shown that sub-
tle structural modifications in a compound can alter
brain permeability [2]. In this study, we prepared six
structurally related fluorescent indoline derivatives (IDs)
as a minimum set of diverse fluorescent compounds and
evaluated their ability to cross the BBB and BRB in live
zebrafish larvae. The BBB and BRB of zebrafish are
structurally and functionally similar to those of mam-
mals [12-14]. Furthermore, zebrafish have been used
successfully to find fluorescent compounds that perme-
ate the BRB [15]. Thus, we used different transparent
zebrafish lines to assess the permeability of the BBB and
BRB to these fluorescent IDs in vivo. We subsequently
focused on the substrate specificity of MRPs to identify
the structural factors influencing the permeability of the
BBB and BRB.
Results
Permeability of the BBB to fluorescent IDs in live
zebrafish larvae
The structures and fluorescent properties of IDs used in
this study are shown in Table 1. Three IDs (ZMB996,
ZMC213 and ZMJ018) of different molecular sizes were
prepared from 1-ethylindoline. The compounds shared a
common rhodanine ring with an acetic acid group. In
addition, we prepared related IDs with a propanoic acid
group instead of an acetic acid group (ZMC808,
ZMB740 and ZMB034).
To examine BBB permeability, we stained zebrafish lar-
vae at 7-8 days post fertilization (dpf) by immersion in
medium containing either one of the six IDs or fluorescein
(MW: 332; Ex: 494 nm / Em: 521 nm). We focused on the
fluorescence signal at the optic tectum (OT), which is a
multilaminated structure with a dense neuropil in which
tectal cell dendrites receive synapses from many neurons
[16] (Figure 1A). Other than in the cerebral blood vessels
(CBV), no obvious fluorescence was observed in the OT
in zebrafish stained with ZMB996, ZMC213 or ZMJ018,
each of which possesses a rhodanine ring with an acetic
acid group (Figure 1B-D). While the overall fluorescence
signal was extremely low in zebrafish stained with
ZMB996 (Figure 1B), weak fluorescence was observed in
the CBV of zebrafish stained with ZMC213 (Figure 1C),
and strong fluorescence was observed in those stained
with ZMJ018 (Figure 1D). The fluorescence signal in the
CBV of zebrafish stained with ZMJ018 was much higher
than that of ZMC213. In contrast to the staining with the
IDs containing a rhodanine ring with an acetic acid group,
fluorescence signals were observed in both the OT and
Table 1 Properties of fluorescent IDs used in this study
Name Structure MW cLogP Ex / Em FI
aceticacid group ZMB996 348.4 2.38 492 / 576 196
ZMC213 388.5 3.25 498 / 570 253
ZMJ018 466.6 4.51 492 / 610 114
propanoicacid group ZMC808 362.5 2.64 501 / 586 139
ZMB740 402.5 3.51 513 / 588 217
ZMB034 480.6 4.77 511 / 627 240
MW, molecular weight; cLogP, calculated octanol/water partition coefficient; Ex, maximum fluorescence excitation; Em, maximum fluorescence emission; FI,
fluorescence intensity.
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ZMB034, all of which contained a rhodanine ring with a
propanoic acid group (Figure 1F-H). The intensity of the
fluorescence signal in the CBV and OT from weakest
to strongest was obtained with ZMC808 < ZMB740 <
ZMB034. This order is consistent with that of the fluores-
cence intensity (FI) of these dyes (Table 1), suggesting that
the intensity of the fluorescence signal in vivo reflects the
FI of each dye. Another possibility is that ZMB034 and
ZMC808 might be the derivatives most and least absorbed
by zebrafish, respectively. Neither the OT nor the CBV
were stained with fluorescein (Figure 1E).
Permeability of the BRB to fluorescent IDs in live
zebrafish larvae
Since the BRB and BBB basically share the same barrier
system, it is reasonable to assume that compounds thatcan permeate the BBB can also permeate the BRB. To
examine this possibility, we performed in vivo imaging of
zebrafish retinas stained with the six fluorescent IDs with
a rhodanine ring with an acetic acid group or a propanoic
acid group (Figure 2). We focused on the fluorescence sig-
nal in the hyaloid blood vessels (HBV; Figure 2A-D, I-K)
and the multiple layers of the retina (Figure 2E-H, L-N).
In the HBV, a strong fluorescence signal was detected in
ZMJ018-stained retinas (Figure 2D), a weak signal in
ZMC213-stained retinas (Figure 2C), and no signal in
ZMB996-stained retinas (Figure 2B). No obvious fluores-
cence signal was observed in the multiple retinal layers in
zebrafish stained with ZMB996 (Figure 2F), ZMC213
(Figure 2G), or ZMJ018 (Figure 2H).
Fluorescence signals were observed in both the HBV
and the multiple retinal layers in zebrafish exposed to
































Figure 2 In vivo assessment of the permeability of the BRB to fluorescent IDs. Zebrafish larvae (albino line) at 7–8 dpf were immersed in
egg water containing 1 μM of ID. In vivo fluorescence imaging of the zebrafish retina was performed using a CLSM. Schematic diagram (A and E)
showing the region of the eye containing the HBV (B-D, I-K) and multiple layers of retina (F-H, L-N) observed using the CLSM. B-D and F-H: In
vivo fluorescence imaging of zebrafish larvae stained with IDs possessing a rhodanine ring with an acetic acid group (ZMB996, ZMC213, and
ZMJ018, B and F, C and G, D and H, respectively). The HBV in zebrafish stained with ZMJ018 were clearly visualized. I-N: In vivo fluorescence
imaging of zebrafish larvae stained with IDs possessing a rhodanine ring with an propanoic acid group (ZMC808, ZMB740, and ZMB034, I and L, J
and M, K and N, respectively). Both the HBV and multiple layers of retina were clearly visualized in zebrafish stained with ZMB034. Bar: 50 μm.
HBV, hyaloid blood vessel; IPL, inner plexiform layer; OPL, outer plexiform layer; PCL, photoreceptor cell layer; GCL, ganglion cell layer; INL, inner























Figure 1 In vivo assessment of the permeability of the BBB to fluorescent compounds. Zebrafish larvae (casper line) at 7–8 dpf were
immersed in egg water containing 1 μM of an ID or fluorescein for 1 h. In vivo fluorescence imaging of the zebrafish brain was performed using
fluorescence microscopes. A: Schematic diagram showing the region observed using the fluorescence microscopes. B-H: In vivo fluorescence
imaging of zebrafish larvae stained with ID possessing a rhodanine ring with an acetic acid group (ZMB996, ZMC213, and ZMJ018, B, C and D,
respectively), with fluorescein (E), and with ID possessing a rhodanine ring with a propanoic acid group (ZMC808, ZMB740, and ZMB034, F, G and
H, respectively). The OT was clearly visualized in zebrafish stained with IDs possessing a rhodanine moiety with a propanoic acid group. Scale bar:
100 μm. OT, optic tectum; CBV, cerebral blood vessel.
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ZMB740 (Figure 2M) and ZMB034 (Figure 2N), fluores-
cence signals were observed in the inner and outer plexi-
form layers (IPL and OPL) and the photoreceptor cell
layer (PCL), whereas fluorescence in the ganglion cell
layer (GCL), inner nuclear layer (INL), and outer nuclear
layer (ONL) appeared reticulated. The IPL and OPL are
synaptic layers that contain neuronal projections from
the INL and GCL, and from the ONL and INL, respect-
ively. The strong fluorescence signals observed in the
IPL and OPL (Figure 2N) of zebrafish stained with
ZMB034 were consistent with strong fluorescence in
the OT where there is an accumulation of synapses
(Figure 1H). The fluorescence signal was weak in zebra-
fish stained with ZMC808 (Figure 2L), which is also con-
sistent with the weak ZMC808-mediated fluorescence























Figure 3 In vivo assessment of the permeability of the BBB permeabi
injection. ZMB034 or ZMJ018 was injected into the cardiac chamber of ze
was performed using a CLSM. A-D: In vivo fluorescence imaging of zebrafis
10 min (A and B) and 30 min (C and D) post-injection. While the CBV were
OT was visualized only in zebrafish treated with ZMB034. E: Quantitative an
30 min after intracardiac injection was significantly higher in zebrafish injec
Scale bar: 50 μm. FI, fluorescence intensity.the permeability of the BRB to fluorescent IDs is similar
to that of the BBB.
Validation of BBB permeability to ZMB034 and ZMBJ018
administered by intracardiac injection
Administration of compounds by immersion might be prob-
lematic because the method is likely to be limited to fish and
amphibian models. Also, it is not clear whether compounds
first enter the blood and then translocate across the BBB
and BRB to the brain and retina, respectively. To circumvent
these problems, we performed intracardiac injection of
ZMB034 or ZMJ018 into zebrafish larvae and assessed the
permeability of the BBB to these IDs. As shown in Figure 3,
fluorescence signal in the OT was clearly present in zebrafish
injected with ZMB034, but not with ZMJ018. The ratio of FI
measured in the OT and the CBV of zebrafish injected with







lity to ZMB034 and ZMJ018 administered by intracardiac
brafish larvae (MK001 line) at 7–8 dpf. In vivo imaging of zebrafish brain
h larvae injected with ZMB034 (A and C) or ZMJ018 (B and D) at
clearly visualized in zebrafish injected with ZMB034 or ZMJ018, the
alysis of FI of the OT relative to the FI of CBV. The relative FI at 10 and
ted with ZMB034 than in those injected with ZMJ018 (n = 4, *P < 0.05).
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ZMJ018 at both 10 and 30 min (Figure 3E). These results
suggest that the permeability of the BBB to IDs is consistent
regardless of either method of exposure.
Assessment of the structural factors influencing the
substrate specificity of MRPs
Efflux of compounds from the brain endothelium is
initiated at the luminal membrane where ATP-binding cas-
sette (ABC) transporters, including MRPs, BCRP, and Pgp,
are the major efflux transporters. MRPs and BCRP largely







































Figure 4 Effect of MK571 on the permeability of the BBB and BRB to
egg water containing 1 μM of ZMJ018 with and without 30 μM of MK571
CLSM. D-I: In vivo fluorescence imaging of the OT (D and G), HBV (E and H
ZMJ018 only (D-F) or ZMJ018 in the presence of MK571 (G-I). The OT and
with ZMJ018 in the presence of MK571. J-L: Quantitative analysis of the FI
OT and the relative FI (OT/HBV) were significantly higher in zebrafish staine
50 μm. OT, optic tectum; CBV, cerebral blood vessel; HBV, hyaloid blood vemediates mainly the efflux of lipophilic neutral and cationic
compounds. According to previous work, MRPs are
expressed in various zebrafish organs, including the brain
and eyes [17,18]. Because the IDs examined in this study
are organic anionic compounds, we examined the effect of
the inhibition of MRPs on the permeability of the BBB and
BRB to ZMJ018. To inhibit MRPs, we used MK571, a se-
lective inhibitor of MRPs that inhibits the activity of MRPs
expressed in zebrafish fibroblast-like cells [18]. Fluorescence
signal in the CBV and HBV was observed after staining
with ZMJ018 alone (Figure 4D-F). In addition to the CBV


































ZMJ018. Zebrafish larvae (albino line) at 7-8 dpf were immersed in
for 4 h. A-C: Schematic diagram showing the regions observed using a
) and multiple layers of the retina (F and I) in zebrafish stained with
multiple layers of the retina were clearly visible in zebrafish stained
in the OT (J) and HBV (K), and the ratio of the FI (L). Both the FI in the
d with ZMJ018 in the presence of MK571 (n = 4, *P < 0.05). Scale bar:
ssel; FI, fluorescence intensity.
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ZMJ018 in the presence of MK571 (Figure 4G-I). The FI in
the OT of zebrafish treated with both ZMJ018 and MK571
was significantly higher than in those treated with ZMJ018
alone (Figure 4J). The FI in the HBV was similar regardless
of MK571 treatment (Figure 4K). The ratio of FI in the OT
and the HBV in zebrafish treated with both ZMJ018 and
MK571 was also significantly higher than in those treated
with ZMJ018 alone (Figure 4L). These results suggest that
ZMJ018 is recognized as a substrate and eliminated from
the BBB and BRB by MRPs.
Discussion
Zebrafish as a useful in vivo model for the assessment of
BBB and BRB permeability to fluorescent compounds
The zebrafish has been shown to be a useful animal model
for studying mechanisms of human disease [19-23], drug dis-
covery for the treatment of human diseases [24], and chem-
ical toxicity [25]. Zebrafish have also been used to research
in vivo fluorescent imaging agents for the visualization of
specific tissues [15]. Accumulating evidence showing similar-
ities between the zebrafish and human BBB and BRB indi-
cates that the zebrafish is a useful research model for
studying the development, maintenance, and function of the
BBB and BRB in vertebrates [12-14]. Jeong and collaborators
[12] injected FITC-dextran (2000 kDa) and rhodamine-
dextran (10 kDa) into zebrafish as extraneous markers. Xie
and colleagues [13] generated a transgenic zebrafish line that
expressed a vitamin D binding protein fused with enhanced
green fluorescent protein (DBP-EGFP) in blood plasma as an
endogenous tracer. These groups analyzed the leakage of
these fluorescent macromolecules from blood vessels and
showed that the zebrafish BBB and BRB, which are regulated
by tight junction proteins, develop by 3 dpf [12,13].
While similarities exists between the zebrafish and
mammalian BBB and BRB [12-14], the contribution of ef-
flux transporters to the function of the zebrafish BBB and
BRB is not yet clear. Genes encoding zebrafish homolo-
gues of MRPs (abcc1, abcc4), MDR (abcb1), and BCRP
(abcg2) have been identified in the zebrafish genome [26].
It has also been shown that abcc1 mRNA is moderately
expressed in the brain and eyes of zebrafish [17]. The
present study revealed that treating zebrafish with
MK571, a selective inhibitor of MRPs including ABCC1
[27], significantly increased the FI of ZMJ018 staining in
both the brain and retina without changing the FI in the
CBV and HBV. These results suggest that ZMJ018 is
recognized as a substrate and eliminated from the BBB
and BRB by MRPs. Thus, efflux transporters in the BBB
and BRB may function in zebrafish in a similar manner to
those of higher vertebrates. Furthermore, the permeability
of a fluorescent ID administered by simple immersion was
comparable to that administered by intracardiac injection,
supporting the validity of administration of fluorescentcompounds to zebrafish by simple immersion for the as-
sessment of BBB and BRB permeability. Used together
with a diversity-oriented fluorescence chemical library
[11], the combination of these zebrafish-based assays
could generate a large amount of information regarding
the relationships between the chemical structure and per-
meability of the BBB and BRB. Such relationships are crit-
ical to the development of clinical drugs and imaging
agents targeting brain and retina [6,28,29]. To our know-
ledge, this is the first report demonstrating that zebrafish
are an excellent model for the analysis of the permeability
of the BBB and BRB to fluorescent compounds, and that
this permeability is mediated through efflux transporters.
Fluorescent IDs as useful compounds for the assessment
of BBB and BRB permeability
Fluorescent compounds have been used for assay sys-
tems focusing on the interactions of efflux transporters
of the BBB in rodent models [29-31]. Fluorescein, a sub-
strate of MRPs, has been used to assess the function of
MRPs and the effects of inhibitors of MRPs by measur-
ing fluorescence intensity in rat brain via micro dialysis
[30]. It has also been shown that rhodamine 800, a sub-
strate of Pgp, can be used to assess the activity of Pgp in
mouse brain by imaging techniques [31]. These findings
suggest that fluorescent substrates of efflux transporters
are useful for examining the function of transporters in
the BBB and BRB in combination with inhibitors of
these transporters. If these fluorescent compounds have
multiple sites for structural modification that might
change their affinity to bind to the transporters, one can
reveal important structural features that regulate the
permeability of the BBB and BRB. In this study, we took
advantage of the indoline scaffold whose structure can
be flexibly modified, and prepared six IDs by combining
three indoline scaffolds of different sizes and rhodanine
derivatives with either acetic acid or propanoic acid.
Indoline and rhodanine alone are not fluorescent but the
rhodanine ring attached to the indoline scaffold exhibits
fluorescence with relatively large Stokes shift [32].
We performed in vivo fluorescence imaging of these
IDs to analyze the permeability across the BBB and BRB
in zebrafish. These IDs were absorbed into the zebrafish
from the medium, whereas fluorescein was not. It has
been shown that zebrafish can absorb chemicals
efficiently from medium into the body when the logP
(octanol/water partition coefficient) exceeds 1 [33,34].
This may be the reason why hydrophilic fluorescein was
not absorbed by the zebrafish. In contrast, the calculated
logP (cLogP) of the IDs ranged from 2 to 5. The fluores-
cence signal of the IDs in the CBV of living zebrafish
corresponded well with their cLogP, suggesting that the
quantities of these IDs absorbed in zebrafish may be cor-
related with their cLogP. Although the lipophilicityof
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ability to cross the BBB and BRB by passive diffusion
[1-8], the lipophilicity of the compounds tested in this
study did not correspond with their cLogP. For example,
although a strong fluorescence signal was observed in
the CBV and HBV of zebrafish stained with ZMJ018,
there was no obvious fluorescence signal in the OT and
the multiple layers of retina. In contrast, both the OT
and the multiple layers of retina were clearly visualized
in zebrafish stained with ZMB034 whose cLogP is very
similar to that of ZMJ018. These results suggest that the
movement of ZMJ018 and ZMB034 across the BBB and
BRB may be regulated by mechanisms other than passive
diffusion.
Pharmacological intervention using a selective inhibitor
of MRPs (MK571) suggested that MRPs pump ZMJ018
across the BBB and BRB from the brain and retina, re-
spectively, to the blood in zebrafish. Comparison of the
chemical structure of ZMJ018 and ZMB034 suggests that
the number of methylene moieties in the terminal car-
boxylic acid group attached to the rhodanine ring may be
critical for recognition by MRPs. In general, the acidity of
carboxylic acid moieties becomes higher as the alkyl sub-
stituent becomes shorter. Thus, the acidity of ZMJ018 may
be higher than that of ZMB034 because ZMJ018 contains
a shorter methylene moiety. Therefore, the recognition of
ZMJ018 by MRPs may be greater than that of ZMB034 be-
cause MRPs mainly recognize anionic compounds as sub-
strates. Alternatively, the affinity of MRPs for ZMB034
may be less than for ZMJ018 if the dissociation rate of the
proton from the terminal carboxylic acid is low. Our pre-
liminary study revealed that fluorescence signals in the
CBV, HBV, and OT were similar between zebrafish treated
only with ZMB034, and zebrafish treated with ZMB034
and MK571, suggesting that MRPs may have a low affinity
for ZMB034. Further studies are required to confirm the
interaction between MRPs and these IDs.
In summary, it is possible to synthesize a diversity-
oriented library of fluorescent IDs because the substruc-
tures can be flexibly modified. These fluorescent IDs can
be applied to the zebrafish-based assay because they
have a good balance between hydrophobicity and hydro-
philicity and can be absorbed into zebrafish from the
medium. Thus, the permeability of the BBB and BRB to
a large number of fluorescent IDs can be assessed using
this zebrafish-based assay.
Conclusions
We were able to demonstrate that in vivo assessment of
the permeability of fluorescent IDs across the BBB and
BRB could be simply and reliably performed using zeb-
rafish. The substructures of IDs can be modified flexibly
and, thus, the ability of a large number of IDs to cross
the BBB and BRB can be assessed using this zebrafish-based assay. The large amount of data acquired from the
assay might be useful for in silico analysis to elucidate
the precise mechanisms underlying the interactions be-
tween chemical structures and the efflux transporters of
the BBB and BRB. A better understanding of the interac-
tions between chemical structures and these efflux trans-
porters will hopefully in turn lead to the efficient design
of compounds targeting the brain and retina.
Methods
Ethics statement
Mie University Institutional Animal Care and Use Com-
mittee guidelines state that no approval is required for
experiments using zebrafish. However, animal experi-
ments described in this manuscript conform to the
ethical guidelines established by the Institutional Animal
Care and Use Committee at Mie University.
Zebrafish strains
The transparent zebrafish mutant line, casper [35], was
obtained from the Aquatic Resources Program, Children’s
Hospital Boston (Boston, MA) and used for the assessment
of BBB permeability (Figure 1). An albino zebrafish line
[36] was obtained from the Max Planck Institute for Devel-
opmental Biology (Tübingen, Germany) and used for the
assessment of BRB and BBB permeability (Figures 2 and 4).
To study BBB permeability, we also crossed nacre [37] and
rose [38] zebrafish to create MieKomachi 001 (MK001), re-
ferred to as the absolute zebrafish line by the Zebrafish
International Resource Center (Figure 3). Zebrafish were
bred and maintained according to the methods described
by Westerfield [39]. Briefly, zebrafish were raised at 28.5 ±
0.5°C with a 14 h/10 h light/dark cycle. Embryos were
obtained via natural mating and cultured in egg water [39].
Compounds
All fluorescent IDs examined in this study (ZMB034,
ZMB740, ZMB996, ZMC213, ZMC808 and ZMJ018)
were obtained from Canon Inc. (Tokyo, Japan). Sodium
fluorescein and MK571 were purchased from Sigma-
Aldrich Co. (St. Louis, MO). Stock solutions (10 mM) of
IDs and sodium fluorescein were dissolved in dimethyl
sulfoxide (DMSO). Fluorescence excitation and emission
spectra and fluorescence intensity of these compounds
were obtained by measuring 5 μM solutions of the fluor-
escent compounds in DMSO with a FL4500 fluorescence
spectrophotometer (Hitachi High-Technologies, Tokyo,
Japan). MW and cLogP were calculated using Chem-
Draw 12.0 (CambridgeSoft Corporation, MA).
Administration of fluorescent compounds into zebrafish
larvae
Zebrafish larvae were exposed to each fluorescent ID or
sodium fluorescein by immersion in egg water containing
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experiments in which MRPs were inhibited, zebrafish were
immersed in egg water containing ZMJ018 (1 μM) with or
without MK571 (30 μM) for 4 h.
For intracardiac injection of ZMB034 and ZMJ018, zeb-
rafish larvae were anesthetized with 2-phenoxyethanol
(500 ppm) and mounted lateral side up in 3% low-melting
agarose. Microinjection pipettes were made from glass ca-
pillaries (1.0 mm diameter, model GD-1, Narishige, Tokyo,
Japan) using a vertical puller (model PC-10, Narishige).
The tip of each pipette was broken and then beveled at a
30° angle with a microgrinder (Narishige). Solutions of
3 mM ZMB034 or ZMJ018 in DMSO were loaded into
the pipette and approximately 1-2 nl was injected into the
ventricle of the beating heart. Thus, the amount of
ZMB034 or ZMJ018 delivered into the circulatory system
was approximately 3-6 pmol, which is comparable to the
amount of fluorescent dextran (10 pmol) injected into the
circulatory system for microangiography in zebrafish [40].
Only zebrafish exhibiting fluorescence in CBV at 10 min
after injection were analyzed.
There are studies analyzing the amount of compounds
in zebrafish immersed in the medium containing the
compounds. When zebrafish embryos were immersed in
the medium containing 15 μM nicotine for 10 min or
4 μM of PFOS for 1 h, the amount of nicotine or PFOS
in the zebrafish embryo was about 10 pmol or 2 pmol,
respectively [41,42]. Together, these previous studies
suggest that similar concentrations of IDs can be
achieved in zebrafish through intracardiac injection of 1-
2 nl of a 3 mM solution and immersion in a 1 μM solu-
tion for 1 h, which were the treatment strategies used in
the present study.
In vivo assessment of the permeability of the BBB and BRB
to fluorescent compounds
After administration of fluorescent compounds, Zebrafish
larvae were washed, anesthetized with 2-phenoxyethanol
(500 ppm), and transferred onto glass slides. A few drops
of 3% methyl-cellulose solution were placed over the lar-
vae and the larvae were immediately oriented on the lat-
eral side. The brain and retina of the embedded larvae
were observed using a Leica MZ16 FA fluorescence
stereomicroscope (Leica Microsystems, Wezlar, Germany),
and a Zeiss 510 confocal laser scanning microscope
(CLSM) using a 20× (NA 0.75) objective lens (Carl Zeiss,
Oberkochen, Germany) according to a previous report
[15]. Excitation was performed at 488 nm and fluores-
cence emission above 505 nm was detected using an
argon laser and a longpass filter, respectively. For the
experiments in which IDs were administered by exposure
in water, the image acquisition setting was fixed within the
same experiment, but the setting varied among different
experiments. All images acquired from the CLSM wereprocessed with a Zeiss LSM Image Browser (Carl Zeiss)
and Volocity (Perkin Elmer, MA, USA).
Quantitative analysis of the in vivo fluorescence imaging
of zebrafish brain and retina
Images were analyzed with ImageJ (http://rsbweb.nih.
gov/ij/index.html) to measure FI. Five circular (diameter,
20 μm) regions of interest (ROI) in the OT, which did
not include any CBV, were generated in each sample
(Figures 3 and 4). Twenty single pixel ROI within CBV
(Figure 3) and HBV (Figure 4) were also generated in
each sample. The mean intensity of these ROIs (circular
or single pixel) was calculated for each sample. Four bio-
logical replicates were performed for each experimental
condition.
Statistical analysis was performed using SAS version
9.1 (SAS Institute, NC). The Student’s t-test was per-
formed to compare the means of two groups. P < 0.05
was considered significant.
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